Research programme: cytomegalovirus vaccine - NovoVacsAlternative Names: Prophylactic CMV vaccine (Cytovax) - Dynavax
Latest Information Update: 05 Dec 2008
At a glance
- Originator NovoVacs BV
- Class Cytomegalovirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 30 Nov 2005 Preclinical trials in Cytomegalovirus infections prevention in Netherlands (unspecified route)